Lattice Biologics Ltd. (LBLTF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | - USD | 0.0% |
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 1.02 Million USD | 8.26% |
| 2019 | 942.76 Thousand USD | 74.21% |
| 2018 | 541.15 Thousand USD | -5.25% |
| 2017 | 571.11 Thousand USD | -30.07% |
| 2016 | 816.69 Thousand USD | 97409.06% |
| 2015 | 837.56 USD | -39.16% |
| 2014 | 1376.56 USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | 0.0% |
| 2010 | - USD | 0.0% |
| 2009 | - USD | 0.0% |
| 2008 | - USD | 0.0% |
| 2007 | - USD | 0.0% |
| 2006 | - USD | 0.0% |
| 2005 | - USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | 0.0% |
| 2000 | - USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q2 | - USD | 0.0% |
| 2023 FY | - USD | 0.0% |
| 2023 Q4 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q1 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2021 Q3 | - USD | -100.0% |
| 2021 Q1 | 228.48 Thousand USD | 7.64% |
| 2021 Q2 | 3789.00 USD | -98.34% |
| 2021 FY | - USD | -100.0% |
| 2020 Q4 | 212.27 Thousand USD | 44.77% |
| 2020 Q1 | 399.88 Thousand USD | 437.5% |
| 2020 Q2 | 261.81 Thousand USD | -34.53% |
| 2020 Q3 | 146.62 Thousand USD | -44.0% |
| 2020 FY | 1.02 Million USD | 8.26% |
| 2019 Q2 | 578.29 Thousand USD | 79.34% |
| 2019 FY | 942.76 Thousand USD | 74.21% |
| 2019 Q1 | 322.46 Thousand USD | 4466.8% |
| 2019 Q3 | 160.48 Thousand USD | -72.25% |
| 2019 Q4 | -118.48 Thousand USD | -173.83% |
| 2018 FY | 541.15 Thousand USD | -5.25% |
| 2018 Q4 | 7061.00 USD | -90.58% |
| 2018 Q3 | 74.93 Thousand USD | -66.09% |
| 2018 Q2 | 220.95 Thousand USD | -7.24% |
| 2018 Q1 | 238.19 Thousand USD | 252.52% |
| 2017 Q2 | 231.4 Thousand USD | -29.15% |
| 2017 Q1 | 326.62 Thousand USD | 406.25% |
| 2017 FY | 571.11 Thousand USD | -30.07% |
| 2017 Q4 | -156.17 Thousand USD | -192.27% |
| 2017 Q3 | 169.26 Thousand USD | -26.85% |
| 2016 Q1 | 310.95 Thousand USD | 121887.85% |
| 2016 Q4 | -106.65 Thousand USD | -131.49% |
| 2016 FY | 816.69 Thousand USD | 97409.06% |
| 2016 Q3 | 338.7 Thousand USD | 23.76% |
| 2016 Q2 | 273.68 Thousand USD | -11.99% |
| 2015 Q4 | 254.91 USD | 34.4% |
| 2015 Q1 | 204.99 USD | 0.0% |
| 2015 Q3 | 189.67 USD | 0.9% |
| 2015 FY | 837.56 USD | -39.16% |
| 2015 Q2 | 187.99 USD | -8.3% |
| 2014 Q3 | - USD | 0.0% |
| 2014 FY | 1376.56 USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 FY | - USD | 0.0% |
| 2011 Q4 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2010 Q4 | - USD | 0.0% |
| 2010 FY | - USD | 0.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q1 | - USD | 0.0% |
| 2009 FY | - USD | 0.0% |
| 2009 Q1 | - USD | 0.0% |
| 2009 Q2 | - USD | 0.0% |
| 2009 Q3 | - USD | 0.0% |
| 2009 Q4 | - USD | 0.0% |
| 2008 FY | - USD | 0.0% |
| 2008 Q4 | - USD | 0.0% |
| 2008 Q1 | - USD | 0.0% |
| 2008 Q3 | - USD | 0.0% |
| 2008 Q2 | - USD | 0.0% |
| 2007 Q1 | - USD | 0.0% |
| 2007 FY | - USD | 0.0% |
| 2007 Q3 | - USD | 0.0% |
| 2007 Q4 | - USD | 0.0% |
| 2007 Q2 | - USD | 0.0% |
| 2006 FY | - USD | 0.0% |
| 2006 Q1 | - USD | 0.0% |
| 2006 Q2 | - USD | 0.0% |
| 2006 Q3 | - USD | 0.0% |
| 2006 Q4 | - USD | 0.0% |
| 2005 FY | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q4 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | 0.0% |
| 2001 Q3 | - USD | 0.0% |
| 2001 Q4 | - USD | 0.0% |
| 2000 FY | - USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| CVR Medical Corp. | - USD | NaN% |
| BioElectronics Corporation | 466.38 Thousand USD | 100.0% |
| IR-Med Inc. | -17 Thousand USD | 100.0% |
| Polarean Imaging plc | 335.48 Thousand USD | 100.0% |
| Medical Supply International USA, Inc. | 1.75 Million USD | 100.0% |
| Avitar, Inc. | 836.7 Thousand USD | 100.0% |
| AVITA Medical, Inc. | 41.68 Million USD | 100.0% |
| Manhattan Scientifics, Inc. | -1000.00 USD | 100.0% |
| Össur hf. | 485.57 Million USD | 100.0% |
| Zecotek Photonics Inc. | -195.32 Thousand USD | 100.0% |
| QHSLab, Inc. | 793.6 Thousand USD | 100.0% |
| Wellstar International, Inc. | - USD | NaN% |
| Össur hf. | 485.57 Million USD | 100.0% |
| Bionovate Technologies Corp | - USD | NaN% |
| EKF Diagnostics Holdings plc | 16.74 Million USD | 100.0% |
| Escalon Medical Corp. | 5.14 Million USD | 100.0% |
| Aurora Spine Corporation | 8.21 Million USD | 100.0% |
| BrainsWay Ltd. | 23.09 Million USD | 100.0% |
| NewCardio, Inc. | 105.1 Thousand USD | 100.0% |
| Hamilton Thorne Ltd. | 35.08 Million USD | 100.0% |
| Vivos Inc. | -6036.00 USD | 100.0% |
| MicroPort Scientific Corporation | 532.09 Million USD | 100.0% |
| Kelyniam Global, Inc. | 2.03 Million USD | 100.0% |
| REMSleep Holdings, Inc. | -756.73 Thousand USD | 100.0% |
| CYduct Diagnostics, Inc. | 56.59 Thousand USD | 100.0% |
| Nanomix Corporation | -69.45 Thousand USD | 100.0% |
| Theraclion SA | -1.08 Million USD | 100.0% |
| Lifeline Biotechnologies, Inc. | - USD | NaN% |
| Wellness Center USA, Inc. | 587.55 Thousand USD | 100.0% |
| Positron Corporation | -353.46 Thousand USD | 100.0% |
| Rafina Innovations Inc. | - USD | NaN% |
| Electromedical Technologies, Inc. | 1.04 Million USD | 100.0% |
| Lombard Medical, Inc. | 955 Thousand USD | 100.0% |
| ALR Technologies Inc. | 4945.00 USD | 100.0% |
| Stratec SE | 71.58 Million USD | 100.0% |
| Vycor Medical, Inc. | 1.31 Million USD | 100.0% |
| Heart Tronics, Inc. | - USD | NaN% |
| Nu-Med Plus, Inc. | -12.9 Thousand USD | 100.0% |
| Perimeter Medical Imaging AI, Inc. | 206.41 Thousand USD | 100.0% |
| SANUWAVE Health, Inc. | 14.36 Million USD | 100.0% |
| VMS Rehab Systems, Inc. | -10.44 USD | 100.0% |
| Guided Therapeutics, Inc. | 36 Thousand USD | 100.0% |
| Ingen Technologies, Inc. | 268.57 Thousand USD | 100.0% |
| Odyssey Group International, Inc. | - USD | NaN% |
| United American Healthcare Corporation | -8000.00 USD | 100.0% |
| ECGI Holdings, Inc. | - USD | NaN% |
| Capital Group Holdings, Inc. | - USD | NaN% |
| ADM Tronics Unlimited, Inc. | 1.09 Million USD | 100.0% |
| Urologix, Inc. | 6.09 Million USD | 100.0% |
| Rapid Therapeutic Science Laboratories, Inc. | - USD | NaN% |
| Nexeon MedSystems Inc. | -316.69 Thousand USD | 100.0% |
| SS Innovations International, Inc. | 713.44 Thousand USD | 100.0% |
| Qualis Innovations, Inc. | - USD | NaN% |
| Smith & Nephew plc | 3.91 Billion USD | 100.0% |
| NIOX Group Plc | 28.13 Million USD | 100.0% |
| Fuse Medical, Inc. | 10.73 Million USD | 100.0% |
| Broncus Holding Corporation | 7.22 Million USD | 100.0% |
| Brain Scientific Inc. | 54.32 Thousand USD | 100.0% |
| Pressure BioSciences, Inc. | 799.56 Thousand USD | 100.0% |
| Health Logic Interactive Inc. | - USD | NaN% |